{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:59:25Z","timestamp":1790197165918,"version":"4.1.0"},"reference-count":32,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.3201\/eid3008.240659","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:45:13Z","timestamp":1721936713000},"page":"1621-1630","source":"Crossref","is-referenced-by-count":24,"title":["Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors"],"prefix":"10.3201","volume":"30","author":[{"given":"Eduard","family":"Grebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mars","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akintunde","family":"Akinseye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Di Germanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bruhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla G.","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Contestable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion C.","family":"Lanteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Saa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad J.","family":"Biggerstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Custer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3008.240659-202407251941-R1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status\u2014United States, April 2021\u2013September 2022.","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3008.240659-202407251941-R2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/cid\/ciaa1116","article-title":"Serosurveillance for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) incidence using global blood donor populations.","volume":"72","author":"Busch","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/vox.12995","article-title":"Research initiatives of blood services worldwide in response to the covid-19 pandemic.","volume":"116","author":"O\u2019Brien","year":"2021","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid3008.240659-202407251941-R4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/cid\/ciab537","article-title":"Use of US blood donors for national serosurveillance of severe acute respiratory syndrome coronavirus 2 antibodies: basis for an expanded national donor serosurveillance program.","volume":"74","author":"Stone","year":"2022","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R5","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated US infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020\u2013May 2021.","volume":"326","author":"Jones","year":"2021","journal-title":"JAMA"},{"key":"key-10.3201\/eid3008.240659-202407251941-R6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jama.2022.9745","article-title":"Updated US infection- and vaccine-induced SARS-CoV-2 seroprevalence estimates based on blood donations, July 2020\u2013December 2021.","volume":"328","author":"Jones","year":"2022","journal-title":"JAMA"},{"key":"key-10.3201\/eid3008.240659-202407251941-R7","unstructured":"Centers for Disease Control and Prevention. 2022 nationwide COVID-19 infection- and vaccination-induced antibody seroprevalence (blood donations). 2023 [cited 2023 Dec 23]. https:\/\/covid.cdc.gov\/covid-data-tracker\/#nationwide-blood-donor-seroprevalence-2022"},{"key":"key-10.3201\/eid3008.240659-202407251941-R8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.7326\/M22-1300","article-title":"Antinucleocapsid antibodies after SARS-CoV-2 infection in the blinded phase of the randomized, placebo-controlled mRNA-1273 COVID-19 vaccine efficacy clinical trial.","volume":"175","author":"Follmann","year":"2022","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid3008.240659-202407251941-R9","doi-asserted-by":"publisher","first-page":"c677","DOI":"10.1093\/ofid\/ofac677","article-title":"Reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection post-vaccination for mild COVID-19 patients.","volume":"10","author":"Dhakal","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R10","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciac353","article-title":"Clinical validation of a novel T-cell receptor sequencing assay for identification of recent or prior severe acute respiratory syndrome coronavirus 2 infection.","volume":"75","author":"Dalai","year":"2022","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41590-021-00902-8","article-title":"Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.","volume":"22","author":"Zuo","year":"2021","journal-title":"Nat Immunol"},{"key":"key-10.3201\/eid3008.240659-202407251941-R12","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/infdis\/jiac420","article-title":"Longitudinal severe acute respiratory syndrome coronavirus 2 vaccine antibody responses and identification of vaccine breakthrough infections among healthcare workers using nucleocapsid immunoglobulin G.","volume":"226","author":"Anderson","year":"2022","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3201\/eid2803.211885","article-title":"Evaluation of commercially available high-throughput SARS-CoV-2 serologic assays for serosurveillance and related applications.","volume":"28","author":"Stone","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1126\/science.abe9728","article-title":"Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.","volume":"371","author":"Buss","year":"2021","journal-title":"Science"},{"key":"key-10.3201\/eid3008.240659-202407251941-R15","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.lanepe.2022.100479","article-title":"Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study.","volume":"21","author":"Erikstrup","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"key-10.3201\/eid3008.240659-202407251941-R16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ijid.2022.01.041","article-title":"Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection.","volume":"116","author":"H\u00f8nge","year":"2022","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R17","doi-asserted-by":"publisher","first-page":"e0323422","DOI":"10.1128\/spectrum.03234-22","article-title":"Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications.","volume":"11","author":"Sulaeman","year":"2023","journal-title":"Microbiol Spectr"},{"key":"key-10.3201\/eid3008.240659-202407251941-R18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/trf.16943","article-title":"How do we\u2026form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?","volume":"62","author":"Fink","year":"2022","journal-title":"Transfusion"},{"key":"key-10.3201\/eid3008.240659-202407251941-R19","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.1093\/cid\/ciac470","article-title":"Population-weighted seroprevalence from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, vaccination, and hybrid immunity among US blood donations from January to December 2021.","volume":"75","author":"Busch","year":"2022","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3008.240659-202407251941-R21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/vaccines10071049","article-title":"Percentage of asymptomatic infections among SARS-CoV-2 Omicron variant-positive individuals: a systematic review and meta-analysis.","volume":"10","author":"Shang","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key-10.3201\/eid3008.240659-202407251941-R22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/oxfordjournals.aje.a112510","article-title":"Estimating prevalence from the results of a screening test.","volume":"107","author":"Rogan","year":"1978","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid3008.240659-202407251941-R23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jinf.2022.08.015","article-title":"Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.","volume":"85","author":"Mizoue","year":"2022","journal-title":"J Infect"},{"key":"key-10.3201\/eid3008.240659-202407251941-R24","doi-asserted-by":"publisher","first-page":"e1475","DOI":"10.1016\/S2214-109X(21)00396-X","article-title":"Intense SARS-CoV-2 transmission among affluent Manaus residents preceded the second wave of the epidemic in Brazil.","volume":"9","author":"Buss","year":"2021","journal-title":"Lancet Glob Health"},{"key":"key-10.3201\/eid3008.240659-202407251941-R25","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/trf.17449","article-title":"SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022.","volume":"63","author":"Bloch","year":"2023","journal-title":"Transfusion"},{"key":"key-10.3201\/eid3008.240659-202407251941-R26","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00238-5","article-title":"Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.","volume":"397","author":"He","year":"2021","journal-title":"Lancet"},{"key":"key-10.3201\/eid3008.240659-202407251941-R27","doi-asserted-by":"publisher","first-page":"e1003877","DOI":"10.1371\/journal.pmed.1003877","article-title":"Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.","volume":"18","author":"Murhekar","year":"2021","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid3008.240659-202407251941-R28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/vox.13625","article-title":"SARS-CoV-2 immunoassays in a predominantly vaccinated population: Performances and qualitative agreements obtained with two analytical approaches and four immunoassays.","volume":"119","author":"Renaud","year":"2024","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid3008.240659-202407251941-R29","doi-asserted-by":"publisher","first-page":"103796","DOI":"10.1016\/j.ebiom.2021.103796","article-title":"Affinity of anti-spike antibodies in SARS-CoV-2 patient plasma and its effect on COVID-19 antibody assays.","volume":"75","author":"Macdonald","year":"2022","journal-title":"EBioMedicine"},{"key":"key-10.3201\/eid3008.240659-202407251941-R30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12879-022-07094-y","article-title":"Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.","volume":"22","author":"Prete","year":"2022","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R31","article-title":"An explanation for reports of increased prevalence of olfactory dysfunction with Omicron: asymptomatic infections.","author":"Von Bartheld","year":"2023","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3008.240659-202407251941-R32","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1111\/trf.15941","article-title":"Use of a rapid electronic survey methodology to estimate blood donors\u2019 potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers.","volume":"60","author":"Whitaker","year":"2020","journal-title":"Transfusion"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/8\/24-0659_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T13:38:33Z","timestamp":1732887513000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/8\/24-0659_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3008.240659","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.23.24307822","asserted-by":"object"}]},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}